Context Active surveillance (AS) is increasingly selected among patients with localized,
intermediate-risk (IR) prostate cancer (PCa). However, the safety and optimal candidate …

Currently, there is no clear consensus regarding the role of active surveillance (AS) in the
management of intermediate-risk prostate cancer (IRPC) patients. We aim to analyse data …

Background and objective Focal therapy (FT) is increasingly recognized as a promising
approach for managing localized prostate cancer (PCa), notably reducing treatment-related …

Background Genomic testing can add risk stratification information to clinicopathological
features in prostate cancer, aiding in shared medical decision-making between the clinician …

Background Active surveillance (AS) is a major management option for men with early
prostate cancer. Current guidelines however advocate identical AS follow-up for all without …

Purpose To develop new selection criteria for active surveillance (AS) in intermediate-risk
(IR) prostate cancer (PCa) patients. Methods Retrospective study including patients from 14 …

Purpose: This study evaluated and synthesized the literature on prostate cancer practice
patterns and patient experience of care within the US Veterans Affairs (VA) population …

Objective We sought to determine, in a prospective long term cohort, the prognostic value of
negative MR imaging with respect to upgrading and need for intervention in men on AS …

Discussion| Among the government-funded academic inventors on US drug patents, the
majority were well-funded senior researchers at prestigious institutions. Many had industry …

In Reply We appreciate the comments provided by Drs Lin and Huang. In theory,
randomized trials could generate unbiased estimates of donor risk; however, randomized …